全文获取类型
收费全文 | 34063篇 |
免费 | 2533篇 |
国内免费 | 576篇 |
专业分类
耳鼻咽喉 | 281篇 |
儿科学 | 466篇 |
妇产科学 | 810篇 |
基础医学 | 3049篇 |
口腔科学 | 476篇 |
临床医学 | 5729篇 |
内科学 | 3606篇 |
皮肤病学 | 268篇 |
神经病学 | 1306篇 |
特种医学 | 830篇 |
外科学 | 4100篇 |
综合类 | 3344篇 |
一般理论 | 2篇 |
预防医学 | 2038篇 |
眼科学 | 89篇 |
药学 | 2580篇 |
12篇 | |
中国医学 | 1067篇 |
肿瘤学 | 7119篇 |
出版年
2024年 | 38篇 |
2023年 | 679篇 |
2022年 | 1232篇 |
2021年 | 1829篇 |
2020年 | 1502篇 |
2019年 | 1928篇 |
2018年 | 1971篇 |
2017年 | 1587篇 |
2016年 | 1195篇 |
2015年 | 1197篇 |
2014年 | 2796篇 |
2013年 | 2633篇 |
2012年 | 1845篇 |
2011年 | 2207篇 |
2010年 | 1591篇 |
2009年 | 1603篇 |
2008年 | 1814篇 |
2007年 | 1440篇 |
2006年 | 1103篇 |
2005年 | 893篇 |
2004年 | 806篇 |
2003年 | 625篇 |
2002年 | 386篇 |
2001年 | 403篇 |
2000年 | 347篇 |
1999年 | 337篇 |
1998年 | 279篇 |
1997年 | 265篇 |
1996年 | 269篇 |
1995年 | 224篇 |
1994年 | 213篇 |
1993年 | 158篇 |
1992年 | 134篇 |
1991年 | 104篇 |
1990年 | 96篇 |
1989年 | 98篇 |
1988年 | 73篇 |
1987年 | 87篇 |
1986年 | 68篇 |
1985年 | 135篇 |
1984年 | 155篇 |
1983年 | 122篇 |
1982年 | 147篇 |
1981年 | 112篇 |
1980年 | 100篇 |
1979年 | 91篇 |
1978年 | 61篇 |
1977年 | 38篇 |
1976年 | 41篇 |
1975年 | 35篇 |
排序方式: 共有10000条查询结果,搜索用时 515 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
3.
4.
痛情绪是指因疼痛引发的情绪和情感体验,是疾病过程中最常见的一种情绪。痛情绪相关神经机制非常复杂,但主要与单胺类神经递质、神经肽和某些神经环路有关,笔者将结合目前研究现状分别从以上两方面展开,就痛情绪相关单胺类神经递质和神经肽在受体分类、脑区通路、共疾病以及各神经递质之间的联系和痛情绪相关神经环路中各个蛋白的作用机制等方面进行探讨。 相似文献
5.
6.
7.
BackgroundRhythmic joint mobilizations (RJM) of the temporomandibular joint (TMJ) are employed to relieve pain and improve function in patients with temporomandibular disorders (TMD). However, the evidence on the immediate effects of RJM in patients with TMD is scarce. The aim of this study was to assess the immediate clinical and functional effects of RJM in patients with TMD.Materials and methodsThis was a one-group quasi-experimental before and after study. Thirty-eight patients with TMD were assessed by means of pain intensity (visual analogue score, VAS), pressure pain threshold (PPT, measured through pressure algometry on the masseter and temporal muscles), mouth opening (MO, measured with a ruler), and surface electromyographic activity of the masseter and temporal muscles (asymmetry index, AI). Measurements were performed before and after a single, 1-min session of RJM of each TMJ. All statistical analyses were performed using the SPSS version 20.0 statistical package.ResultsA statistical significant difference was found in pain intensity, PPT and MO after the intervention (p < 0.05). No difference was found in the AI. A large effect size was observed for pain intensity, PPT of the left and right masseter muscles and MO (d = 0.85–1.13), whereas for the left and right temporal muscles the effect size was moderate (d = 0.62) and small, respectively (d = 0.49).ConclusionIn this sample of patients with TMD, a single session of RJM of the TMJ seemed to be effective in reducing pain intensity, increasing PPT and improving MO immediately after the intervention, without differences in the AI. 相似文献
8.
9.
《Transfusion and apheresis science》2022,61(4):103488
The COVID-19 pandemic caused by the SARS-CoV-2 virus has significantly disrupted and burdened the diagnostic workup and delivery of care, including transfusion, to cancer patients across the globe. Furthermore, cancer patients suffering from solid tumors or hematologic malignancies were more prone to the infection and had higher morbidity and mortality than the rest of the population. Major signaling pathways have been identified at the intersection of SARS-CoV-2 and cancer cells, often leading to tumor progression or alteration of the tumor response to therapy. The reactivation of oncogenic viruses has also been alluded to in the context and following COVID-19. Paradoxically, certain tumors responded better following the profound infection-induced immune modulation. Unveiling the mechanisms of the virus-tumor cell interactions will lead to a better understanding of the pathophysiology of both cancer progression and virus propagation. It would be challenging to monitor, through the different cancer registries, retrospectively, the response of patients who have been previously exposed to the virus in contrast to those who have not contracted the infection. 相似文献
10.